Home › Asset managers › Compare 2023-2024 › BlackRock vs Jackson National
BlackRock 2023-2024 · Jackson National 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 14,306 | 11,879 | 1,357 | 1,070 | 89.7% | 87.1% |
| Board proposals | 11,778 | 9,595 | 1,228 | 955 | 88.7% | 85.7% |
| E&S shareholder proposals | 14 | 9 | 1 | 4 | 90.0% | 90.5% |
| Other items | 2,514 | 2,275 | 128 | 111 | 94.7% | 93.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,228 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | Jackson National |
|---|---|---|---|---|---|---|
| WIZZ AIR HOLDINGS PLC | August 2, 2023 | Re-elect Anthony Radev as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| WIZZ AIR HOLDINGS PLC | August 2, 2023 | Re-elect Anthony Radev as Director (Independent Shareholder Vote) Director Elections |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| WORKIVA INC. | May 30, 2024 | Approval of the Amendment and Restatement of the Workiva Inc. 2014 Equity Incentive Plan to increase the number of shares that may be issued under the Plan. Compensation |
Board | For | FOR 20 funds |
AGAINST 4 funds |
| XP INC. | October 6, 2023 | APPROVAL AND RATIFICATION OF THE REAPPOINTMENT OF EACH OF GUILHERME DIAS FERNANDES BENCHIMOL, BRUNO CONSTANTINO ALEXANDRE DOS SANTOS, BERNARDO AMARAL BOTELHO, FABRICIO CUNHA DE ALMEIDA, MARTIN EMILIANO ESCOBARI LIFCHITZ, GABRIEL KLAS DA ROCHA LEAL, LUIZ FELIPE AMARAL CALABRO AND CRISTIANA PEREIRA AS DIRECTORS. Director Elections |
Board | For | FOR 24 funds |
AGAINST 1 fund |
| XP INC. | May 24, 2024 | Approval of the appointment of Melissa Werneck as an independent director. Director Elections |
Board | For | FOR 26 funds |
AGAINST 1 fund |
| XP INC. | May 24, 2024 | Approval of the reappointment of Gabriel Klas da Rocha Leal as a director. Director Elections |
Board | For | FOR 26 funds |
AGAINST 1 fund |
| XP INC. | May 24, 2024 | Approval of the reappointment of Guilherme Dias Fernandes Benchimol as a director. Director Elections |
Board | For | FOR 26 funds |
AGAINST 1 fund |
| XVIVO PERFUSION AB | April 25, 2024 | Approve Remuneration Report Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| XVIVO PERFUSION AB | April 25, 2024 | Reelect Gosta Johannesson as Board Chair Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| XVIVO PERFUSION AB | April 25, 2024 | Reelect Gosta Johannesson as Director Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| XVIVO PERFUSION AB | April 25, 2024 | Reelect Lars Henriksson as Director Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| XVIVO PERFUSION AB | April 25, 2024 | Reelect Lena Hoglund as Director Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | Election of Directors: Johan Wedell-Wedellsborg Director Elections |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | Election of Directors: Michael Rossi Director Elections |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | Election of Directors: Thomas Gad Director Elections |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | To approve, on a non-binding advisory vote basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 1 fund |
| Y. H. DIMRI BUILDING & DEVELOPMENT LTD. | June 10, 2024 | Reelect Assi Horev as Director Director Elections |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| Y. H. DIMRI BUILDING & DEVELOPMENT LTD. | June 10, 2024 | Reelect Dina Sabban as Director Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| YEXT INC. | June 12, 2024 | Election of Class I Directors: Evan Skorpen Director Elections |
Board | For | FOR 13 funds |
ABSTAIN 2 funds |
| YEXT INC. | June 12, 2024 | Election of Class I Directors: Julie Richardson Director Elections |
Board | For | FOR 13 funds |
ABSTAIN 2 funds |
| YPSOMED HOLDING AG | June 26, 2024 | Reappoint Gilbert Achermann as Member of the Nomination and Compensation Committee Director Elections |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| YPSOMED HOLDING AG | June 26, 2024 | Reelect Gilbert Achermann as Director and Board Chair Director Elections |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| YPSOMED HOLDING AG | June 26, 2024 | Reelect Simon Michel as Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ZENTALIS PHARMACEUTICALS INC. | June 21, 2024 | Election of Class I Directors to serve until the 2027 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Kimberly Blackwell, M.D. Director Elections |
Board | For | FOR 10 funds |
ABSTAIN 2 funds |
| ZIPRECRUITER INC. | June 11, 2024 | Election of Class III Directors for three-year term: Blake Irving Director Elections |
Board | For | FOR 15 funds |
ABSTAIN 1 fund |
| ZIPRECRUITER INC. | June 11, 2024 | Election of Class III Directors for three-year term: Emily McEvilly Director Elections |
Board | For | FOR 15 funds |
ABSTAIN 1 fund |
| ZOOMINFO TECHNOLOGIES INC. | May 15, 2024 | To elect the director nominees listed in the Proxy Statement: Henry Schuck Director Elections |
Board | For | FOR 26 funds |
ABSTAIN 6 funds |
| ZOOMINFO TECHNOLOGIES INC. | May 15, 2024 | To elect the director nominees listed in the Proxy Statement: Keith Enright Director Elections |
Board | For | WITHHOLD 26 funds |
ABSTAIN 6 funds |
← Previous Page 13 of 13
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.